A citation-based method for searching scientific literature

Nicky Dekker, Eleonora B L van Dorst, Rob B van der Luijt, Marielle E van Gijn, Marc van Tuil, Johan A Offerhaus, Margreet G E M Ausems. J Genet Couns 2013
Times Cited: 6







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Endometrial cancer patients and compliance with genetic counseling: room for improvement.
Floor J Backes, Elizabeth Mitchell, Heather Hampel, David E Cohn. Gynecol Oncol 2011
33
50

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
696
50

Factors influencing patients' decisions to decline cancer genetic counseling services.
K P Geer, M E Ropka, W F Cohn, S M Jones, S Miesfeldt. J Genet Couns 2001
62
50

Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
Sue V Petzel, Rachel Isaksson Vogel, Tracy Bensend, Anna Leininger, Peter A Argenta, Melissa A Geller. J Genet Couns 2013
29
50

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
33

Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
M J Esplen, L Madlensky, M Aronson, H Rothenmund, S Gallinger, K Butler, B Toner, J Wong, M Manno, J McLaughlin. Clin Genet 2007
46
33


Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Heather Hampel, Wendy Frankel, Jenny Panescu, Janet Lockman, Kaisa Sotamaa, Daniel Fix, Ilene Comeras, Jennifer La Jeunesse, Hidewaki Nakagawa, Judith A Westman,[...]. Cancer Res 2006
389
33

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
33

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
582
33

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout, Margreet G E M Ausems. Genet Med 2007
54
33

Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.
Béatrice Godard, Annabelle Pratte, Martine Dumont, Adèle Simard-Lebrun, Jacques Simard. Genet Test 2007
33
33

Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
Angela George, Stan Kaye, Susana Banerjee. Nat Rev Clin Oncol 2017
90
33

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
59
33

What women with ovarian cancer think and know about genetic testing.
Robin A Lacour, Molly S Daniels, Shannon N Westin, Larissa A Meyer, Catherine C Burke, Kimberly A Burns, Shiney Kurian, Nicki F Webb, Terri B Pustilnik, Karen H Lu. Gynecol Oncol 2008
49
33

Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
Paul A Cohen, Cassandra B Nichols, Lyn Schofield, Steven Van Der Werf, Nicholas Pachter. Int J Gynecol Cancer 2016
18
33

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
Amit M Oza, David Cibula, Ana Oaknin Benzaquen, Christopher Poole, Ron H J Mathijssen, Gabe S Sonke, Nicoletta Colombo, Jiří Špaček, Peter Vuylsteke, Holger Hirte,[...]. Lancet Oncol 2015
344
33

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen, Harvey A Risch, Isabel Fan, Linda Bradley, Patricia A Shaw, Steven A Narod. Gynecol Oncol 2011
246
33

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
505
33



Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.
Beth N Peshkin, Tiffani A Demarco, Kristi D Graves, Karen Brown, Rachel H Nusbaum, Diana Moglia, Andrea Forman, Heiddis Valdimarsdottir, Marc D Schwartz. Genet Test 2008
43
16

Being 'at-risk' for developing cancer: cognitive representations and psychological outcomes.
Shoshana Shiloh, Erga Drori, Avi Orr-Urtreger, Eitan Friedman. J Behav Med 2009
21
16

Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
A R Bradbury, L Patrick-Miller, D Fetzer, B Egleston, S A Cummings, A Forman, L Bealin, C Peterson, M Corbman, J O'Connell,[...]. Clin Genet 2011
30
16

Recommendations for Telephone Counseling.
K E Ormond, J Haun, L Cook, D Duquette, C Ludowese, A L Matthews. J Genet Couns 2000
26
16

Cancer genetic risk assessment for individuals at risk of familial breast cancer.
Jennifer S Hilgart, Bernadette Coles, Rachel Iredale. Cochrane Database Syst Rev 2012
49
16

Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.
Kurt D Christensen, J Scott Roberts, David I Shalowitz, Jessica N Everett, Scott Y H Kim, Leon Raskin, Stephen B Gruber. Cancer Epidemiol Biomarkers Prev 2011
38
16

BRCA1/2 genetic testing in the community setting.
Wendy Y Chen, Judy E Garber, Suzanne Higham, Katherine A Schneider, Katie B Davis, Amie M Deffenbaugh, Thomas S Frank, Rebecca S Gelman, Frederick P Li. J Clin Oncol 2002
47
16


Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred.
Anita Yeomans Kinney, Sara Ellis Simonsen, Bonnie Jeanne Baty, Diptasri Mandal, Susan L Neuhausen, Kate Seggar, Richard Holubkov, Lindsey Bloor, Ken Smith. J Genet Couns 2006
35
16


Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
L Baumanis, J P Evans, N Callanan, L R Susswein. J Genet Couns 2009
55
16

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
146
16

Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
Jean Jenkins, Kathleen A Calzone, Eileen Dimond, David J Liewehr, Seth M Steinberg, Oxana Jourkiv, Pam Klein, Peter W Soballe, Sheila A Prindiville, Ilan R Kirsch. Genet Med 2007
53
16

Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer.
Ch Halbert, L Kessler, A Collier, E Paul Wileyto, K Brewster, B Weathers. Clin Genet 2005
18
16

Communicating the result of breast biopsy by telephone or in person.
L Campbell, R M Watkins, C Teasdale. Br J Surg 1997
12
16

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
71
16

Enhanced counselling for women undergoing BRCA1/2 testing: Impact on knowledge and psychological distress-results from a randomised clinical trial.
Pagona Roussi, Kerry Anne Sherman, Suzanne Miller, Joanne Buzaglo, Mary Daly, Alan Taylor, Eric Ross, Andrew Godwin. Psychol Health 2010
18
16


Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care.
Karyn B Stitzenberg, Yu-Ning Wong, Matthew E Nielsen, Brian L Egleston, Robert G Uzzo. Cancer 2012
105
16

Cancer genetic counseling: communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment.
Arwen H Pieterse, Alexandra M van Dulmen, Frits A Beemer, Jozien M Bensing, Margreet G E M Ausems. J Genet Couns 2007
48
16

The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation.
Anita Yeomans Kinney, Lindsey E Bloor, Diptasri Mandal, Sara Ellis Simonsen, Bonnie Jeanne Baty, Richard Holubkov, Kate Seggar, Susan Neuhausen, Ken Smith. Cancer 2005
30
16

Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations.
Kimberly Kelly, Howard Leventhal, Michael Andrykowski, Deborah Toppmeyer, Judy Much, James Dermody, Monica Marvin, Jill Baran, Marvin Schwalb. Psychooncology 2005
59
16

Delivery of genomic medicine for common chronic adult diseases: a systematic review.
Maren T Scheuner, Pauline Sieverding, Paul G Shekelle. JAMA 2008
214
16

Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.
Henry T Lynch, Carrie Snyder, Jane F Lynch, Peggy Karatoprakli, Abdon Trowonou, Kelly Metcalfe, Steven A Narod, Gordon Gong. Cancer Genet Cytogenet 2006
51
16

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, Carol J Fabian, Ian S Fentiman, Mark E Robson, Susan M Domchek, Lynn C Hartmann, Roland Holland, David J Winchester. Cancer 2008
64
16

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
298
16

Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Kimberly Kelly, Howard Leventhal, Monica Marvin, Deborah Toppmeyer, Jill Baran, Marvin Schwalb. Cancer Control 2004
28
16

The validity of the Hospital Anxiety and Depression Scale. An updated literature review.
Ingvar Bjelland, Alv A Dahl, Tone Tangen Haug, Dag Neckelmann. J Psychosom Res 2002
16

Genetic testing for inherited breast cancer risk in African Americans.
Chanita Hughes Halbert, Lisa Jay Kessler, Edith Mitchell. Cancer Invest 2005
44
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.